EMAS clinical guide: Low-dose vaginal estrogens for postmenopausal vaginal atrophy-Reference-Cited by-同舟云学术

EMAS clinical guide: Low-dose vaginal estrogens for postmenopausal vaginal atrophy

Published:2012-10 Issue:2 Volume:73 Page:171-174
ISSN:0378-5122
Container-title:Maturitas
language:en
Short-container-title:Maturitas

Author:

Rees Margaret,Pérez-López Faustino R.,Ceasu Iuliana,Depypere Herman,Erel Tamer,Lambrinoudaki Irene,Schenck-Gustafsson Karin,Simoncini Tommaso,van der Schouw Yvonne T.,Tremollieres Florence

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,General Biochemistry, Genetics and Molecular Biology

Reference30 articles.

1. Self-reported urogenital symptoms in postmenopausal women: women's health initiative;Pastore;Maturitas,2004

2. Women's voices in the menopause: results from an international survey on vaginal atrophy;Nappi;Maturitas,2010

3. Efficacy and tolerability of local estrogen therapy for urogenital atrophy;Archer;Menopause,2010

4. Systemic and topical hormone therapies reduce vaginal innervation density in postmenopausal women;Griebling;Menopause,2012

5. Local oestrogen for vaginal atrophy in postmenopausal women;Suckling;Cochrane Database Systematic Reviews,2006

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vulvovaginal atrophy: current methods of diagnosis and treatment;Bulletin of Siberian Medicine;2024-04-11

2. New Possibilities for Hormonal Vaginal Treatment in Menopausal Women;Journal of Clinical Medicine;2023-07-18

3. The role of hormone therapy in urogenital health after menopause;Best Practice & Research Clinical Endocrinology & Metabolism;2021-12

4. Management of postmenopausal vulvovaginal atrophy: recommendations of the International Society for the Study of Vulvovaginal Disease;Gynecological Endocrinology;2021-06-25

5. Topical estrogens and non-hormonal preparations for postmenopausal vulvovaginal atrophy: An EMAS clinical guide;Maturitas;2021-06